CD5-14560-17599
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 271 / NC
- Registered
- 2021-07-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-20
Registered in v-safe
-
2021-07-20
Dose 1 — Pfizer-BioNTech
- 2021-07-20
- 2021-07-21
- 2021-07-22
- 2021-07-23
- 2021-07-24
- 2021-07-25
- 2021-07-26
- 2021-07-27
- 2021-08-03
-
2021-08-12
Dose 2 — Pfizer-BioNTech
- 2021-08-12
-
2021-08-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-08-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-08-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-08-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-26
- 2021-09-02
- 2021-09-16
- 2021-11-11
- 2022-02-12
-
2022-08-12
Survey response — 12 months, dose 2MedDRA: Cough, Diarrhoea, Hypogeusia, Hyposmia, Nasal disorder, Oropharyngeal pain, Pain, Paranasal sinus discomfort, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had positive Covid test; aches and pains, cough, sore throat, sinus pressure, nasal changes, diarrhea, and reduced sense of taste and smellMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-20 | Pfizer-BioNTech | No |
| 2 | 2021-08-12 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 2
Symptoms: Had positive Covid test; aches and pains, cough, sore throat, sinus pressure, nasal changes, diarrhea, and reduced sense of taste and smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Nasal disorder | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release